Embecta (EMBC) EPS (Weighted Average and Diluted) (2021 - 2026)

Embecta has disclosed EPS (Weighted Average and Diluted) across 6 years of filings, most recently posting -$0.07 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.07, down 117.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.89 (up 112.36% YoY), and the FY2025 annual result was $1.62, up 20.9% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.07 for Q1 2026 at Embecta, down from $0.74 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.38 in Q1 2022 to a low of -$0.25 in Q3 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.38 (2023), against an average of $0.44.
• Across the five-year window, EPS (Weighted Average and Diluted) jumped 212.0% in 2025 and slumped 117.5% in 2026, its largest moves.
• Embecta's EPS (Weighted Average and Diluted) stood at $0.61 in 2022, then plunged by 42.62% to $0.35 in 2023, then plunged by 31.43% to $0.24 in 2024, then soared by 208.33% to $0.74 in 2025, then sank by 109.46% to -$0.07 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.07 (Q1 2026), $0.74 (Q4 2025), and $0.44 (Q3 2025), per Business Quant data.